Variants and differential diagnosis of Guillain–Barré syndrome

References

• Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculo-névrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction cellulaire: remarques sur les caracteres cliniques et graphiques des reflexes tendineux. Bull. Soc. Med. Hop. Paris 40, 1462–1470 (1916).
   Google Scholar
• Hughes RAC, Rees JH. Clinical and epidemiologic features of Guillain—Barré syndrome. .1. Infect. Dis. 176\(Suppl. 2), S92—S98 (1997).
   Google Scholar
• Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain—Barré syndrome. Ann. Neurol. 3, 565–566 (1978).
   PubMedGoogle Scholar
• Thomas PK. The Guillain—Barré syndrome: no longer a simple concept. .1. Neurol. 239,361-362 (1992).
   Google Scholar
• van der Meché FGA, van Doom PA, Meulstee J, Jennekens FGI, for the GBS-consensus group of the Dutch Neuromuscular Research Support Centre. Diagnostic and classification criteria for the Guillain—Barré syndrome. Eur. Neurol. 45, 133–139 (2001).
   Google Scholar
• Yuki N, Hirata K. Preserved tendon reflexes in Campylobacterneuropathy. Ann. Neurol. 43,546–547 (1998).
   PubMed Web of Science ®Google Scholar
• Odaka M, Yuki N, Hirata K. AntiGQ lb antibody syndrome: clinical and immunological range. j Neurol. Neurosurg. Psychiatry 70,50–55 (2001).
   Google Scholar
• Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine 48, 173–215 (1969).
   PubMed Web of Science ®Google Scholar
• McKhann GM, Cornblath DR, Griffin JW et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33,333–342 (1993).
   PubMed Web of Science ®Google Scholar
• •Initial description of acute motor axonal varient. toGriffin JVV, Li CY, Ho TW et al. Pathology of the motor-sensory axonal Guillain—Barré syndrome. Ann. Neurol. 39,17-28 (1996).
   Google Scholar
• Kuwabara S, Yuki N, Koga M eta]. IgG antiGM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain—Barré syndrome. Ann. Neurol. 44,202-208 (1998).
   Google Scholar
• Feasby TE, Gilbert JJ, Brown WF etal. An acute axonal form of Guillain—Barré polyneuropathy. Blain 109,1115–1126 (1986).
   Google Scholar
• •Initial description of acute sensory motor axonal varient.
   Google Scholar
• Ho TW, Li CY, Cornblath DR et al. Patterns of recovery in the Guillain—Barré syndromes. Neurology48, 695–700 (1997).
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Asahina M, Koga M, Mori M, Yuki N, Hattori T. Two patterns of clinical recovery in Guillain—Barré syndrome with antiGM1 antibody. Neurology51,1656–1660 (1998).
   PubMed Web of Science ®Google Scholar
• Griffin JVV, Li CY, Macko C et al. Early nodal change in the acute motor axonal neuropathy pattern of the Guillain—Barré syndrome. .1. Neurocytol. 25,33-51 (1996).
   Google Scholar
• Quarles RH, Weiss MD. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 22,800–822 (1999).
   PubMed Web of Science ®Google Scholar
• O'Leary CP, Willison HJ. The role of antiglycolipid antibodies in peripheral neuropathies. Curt: Opin. Neurol. 13,583–588 (2000).
   Web of Science ®Google Scholar
• Yuki N. Infectious origins of and molecular mimicry in, Guillain-Barré and Fisher syndrome. Lancet 1,29–37 (2001).
   Google Scholar
• Kornberg AJ, Pestronk A, Bieser K et al. The clinical correlates of high-titer IgG antiGM1 antibodies. Ann. Neurol. 35, 234–237 (1994).
   Google Scholar
• Kusunoki S, Iwamori M, Chiba A, Hitoshi S, Arita M, Kanazawa I. GM lb is a new member of antigen [sic] for serum antibody in Guillain—Barré syndrome. Neurology 47, 237–242 (1996).
   PubMed Web of Science ®Google Scholar
• Rees JH, Gregson NA, Hughes RAC. Antiganglioside GM1 antibodies in Guillain—Barré syndrome and their relationship to Campylobacterjtjuni infection. Ann. Neurol. 38,809-816 (1995).
   Google Scholar
• Jacobs BC, van Doom PA, Schmitz PI eta]. Campylobacterjtjuni infections and antiGM1 antibodies in Guillain—Barré syndrome. Ann. Neurol. 40,181-187 (1996).
   Google Scholar
• Hadden RDM, Cornblath DR, Hughes RAC et al. Electrophysiological classification of Guillain—Barré syndrome: clinical association and outcome. Ann. Neurol. 44,780–788 (1998).
   PubMed Web of Science ®Google Scholar
• Carpo M, Pedotti R, Allaria S et al. Clinical presentation and outcome of Guillain—Barré and related syndromes in relation to antiganglioside antibodies. .1. Neurol. Sci. 168,78-84 (1999).
   Google Scholar
• Ho TW, Willison HJ, Nachamkin I et al. AntiGD1a antibody is associated with axonal but not demyelinating forms of Guillain—Barré syndrome. Ann. Neurol. 45, 168–173 (1999).
   Google Scholar
• Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain—Barré syndrome: relation to antiganglioside antibodies and Campylobacterjtjuni infection in Japan. Ann. Neurol. 48,624–631 (2000).
   PubMed Web of Science ®Google Scholar
• Yuki N, Kuwabara S, Koga M, Hirata K. Acute motor axonal neuropathy and acute motor—sensory axonal neuropathy share a common immunological profile. .1. Neurol. Sci. 168,121-126 (1999).
   Google Scholar
• Ravindranath MH, Ravindranath RMH, Morton DL, Graves MC. Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA. Immunol. Methods 169,257–272 (1994).
   PubMed Web of Science ®Google Scholar
• Willison HJ, Veitch J, Swan AV et al. Inter- laboratory validation of an ELISA for the determination of serum antiganglioside antibodies. Eur. Neurol. 6,71–77 (1999).
   Web of Science ®Google Scholar
• Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. Guillain—Barré syndrome variants in Emilia-Romagna, Italy, 1992–3: incidence, clinical features and prognosis. j Neurol. Neurosurg. Psychiatry65,218–224 (1998).
   Google Scholar
• Ropper AH, Wijdicks EFM, Truax BT. Guillain—Barré syndrome. FA Davis Company, Philadelphia, USA, 18–21,106-121 (1991).
   Google Scholar
• Pryor WM, Freiman JS, Gillies MA, Tuck RR. Guillain—Barré syndrome associated with Campylobacter infection. Aust. NZ,J. Med. 14,687–688 (1984).
   PubMedGoogle Scholar
• Kuwabara S, Ogawara K, Koga M, Mori M, Hattori T, Yuki N. Hyperreflexia in Guillain—Barré syndrome: relation with acute motor axonal neuropathy and antiGM1 antibody. .1. Neurol. Neurosurg. Psychiatry67, 180–184 (1999).
   Google Scholar
• Podnar S, Vodus-ek DB. Hyperreflexia in a patient with motor axonal Guillain—Barré syndrome. Eur j Neurol. 7,727–730 (2000).
   PubMed Web of Science ®Google Scholar
• Fisher M. An unusual variant of acute idiopathic polyneuritis: syndrome of ophthalmoplegia, ataxia and areflexia. N EngLj Med. 255,57–65 (1956).
   PubMed Web of Science ®Google Scholar
• Ropper AH, Shahani B. Proposed mechanism of ataxia in Fisher's syndrome. Arch. Neurol. 40,537–538 (1983).
   PubMedGoogle Scholar
• Kuwabara S, Asahina M, Nakajima M eta]. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann. Neurol. 45,533–536 (1999).
   Google Scholar
• Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum antiGQ lb IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain—Barré syndrome: clinical and immunohistochemical studies. Neurology 43,1911–1917 (1993).
   PubMed Web of Science ®Google Scholar
• Bickerstaff ER. Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis. Br. Med. j i, 1384–1387 (1957).
   Google Scholar
• Bickerstaff ER, Cloake PCP. Mesencephalitis and rhombencephalitis. Br. Med. J ii, 77–81 (1951).
   Google Scholar
• Yuki N, Wakabayashi K, Yamada M, Seki K. Overlap of Guillain—Barré syndrome and Bickerstaff's brainstem encephalitis. j Neurol. Sci. 145,119–122 (1997).
   PubMed Web of Science ®Google Scholar
• Odaka M, Yuki N, Hirata K. Bickerstaff brainstem encephalitis with and without limb weakness: the relationship. j Neurol. Sci. 187(Suppl.), 489 (2001).
   Google Scholar
• Richter RB. The ataxic form of polyradiculoneuritis (Landry—Guillain—Barré syndrome). J Neuropathol. Exp. Neurol. 21,171–184 (1962).
   PubMed Web of Science ®Google Scholar
• Mod M, Kuwabara S, Koga M et al. IgG antiGQ lb positive acute ataxia without ophthalmoplegia. j Neurol. Neurosurg. Psychiatry 67,668–670 (1999).
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Chiba A, Kanazawa I. AntiGQ lb IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 22,1071–1074 (1999).
   Google Scholar
• Yuki N, Susuki K, Hirata K. Ataxic Guillain—Barré syndrome with antiGQ lb antibody: relation to Miller Fisher syndrome. Neurology 54,1851–1853 (2000).
   PubMed Web of Science ®Google Scholar
• Yuki N. Acute paresis of extraocular muscles associated with IgG antiGQ lb antibody. Ann. Neurol. 39,668–672 (1996).
   PubMed Web of Science ®Google Scholar
• Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with antiGQ lb IgG antibody: clinical features. Ophthalmology108,196–200 (2001).
   PubMed Web of Science ®Google Scholar
• Ropper AH. Further regional variants of acute immune polyneuropathy. Arch. Neurol. 51,671–675 (1994).
   PubMedGoogle Scholar
• Ropper AH. Unusual clinical variants and signs in Guillain—Barré syndrome. Arch. Neurol. 43,1150–1152 (1986).
   PubMed Web of Science ®Google Scholar
• Koga M, Yuki N, Hirata K. Antiganglioside antibody in patients with Guillain—Barré syndrome who show bulbar palsy as an initial symptom. j Neurol Neurosurg. Psychiatry66, 513–516 (1999).
   Google Scholar
• Wöhrle JC, Spengos K, Steinke W Goebel HH, Hennerici M. Alcohol-related acute axonal polyneuropathy: differential diagnosis Guillain—Barré syndrome. Arch. Neurol. 55,1329-1334 (1998).
   Google Scholar
• Yuki N, Hirata K. Relation between critical illness polyneuropathy and axonal Guillain—Barré syndrome. j Neurol. Neurosurg. Psychiatry 67,128–129 (1999).
   PubMed Web of Science ®Google Scholar
• Buruma OJS, Schipperheyn JJ. Periodic paralysis. In: Diseases of muscle, Part IL Handbook of Clinical Neurology (Volume 41). Vinken PJ, Bruyn GW (Eds). North-Holland Publishing Company, Amsterdam, The Netherlands, 147–174 (1979).
   Google Scholar
• Evers S, Engelien A, Karsch V, Hund M. Secondary hyperkalaemic paralysis. j Neurol. Neurosurg. Psychiatry 64,249–252 (1998).
   PubMed Web of Science ®Google Scholar
• Windebank AJ, Bonkovlsky HL. Porphyric neuropathy. In: Peripheral Neuropathy, (3rd Edition). Dyck PJ, Thomas PK, Griffin JW, Low PA, Podulso JF (Eds). WB Saunders, Philadelphia, USA, 1161–1168 (1993).
   Google Scholar
• Sluga E, Donis J. Deficiency neuropathies. In: Neuropathies, Handbook of Clinical Neurology [Volume 7(51)1. Vinken PJ, Bruyn GW, Klawans HL (Eds). North-Holland Publishing Company, Amsterdam, The Netherlands, 321–354 (1987).
   Google Scholar
• Koike H, Misu K, Hattori N et al. Postgastrectomy polyneuropathy with thiamine deficiency. j Neurol. Neurosurg. Psychiatry71, 357–362 (2001).
   PubMed Web of Science ®Google Scholar
• Windebank AJ. Metal neuropathy. In: Peripheral Neuropathy, (3rd Edition). Dyck PJ, Thomas PK, Griffin JVV, Low PA. Podulso JF (Eds). WB Saunders, Philadelphia, USA, 1161–1168 (1993).
   Google Scholar
• Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain—Barré syndrome. j Neurol. Neurosurg. Psychiatry 49,563–573 (1986).
   PubMed Web of Science ®Google Scholar
• de Letter MACJ, Visser LH, Ang W, van der Meché FGA, Savelkoul HFJ. Distinctions between critical illness polyneuropathy and axonal Guillain—Barré syndrome. J Neurol. Neurosurg. Psychiatry 68,397–398 (2000).
   Google Scholar
• Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann. Int. Med. 129, 221–228 (1998).
   Google Scholar
• Cherington M, Smith RH, Montecucco C. Microbial toxins. In: Intoxications of the Nervous System, Part IL Handbook of Clinical Neurology [Volume 21 (65)1. Vinken PJ, Bruyn GW (Eds). North-Holland Publishing Company, Amsterdam, The Netherlands, 209-215(1995).
   Google Scholar
• Logina I, Donaghy M. Diphtheritic polyneuropathy: a clinical study and comparison with Guillain—Barré syndrome. Neurol. Neurosurg. Psychiatry67,433–435 (1999).
   PubMed Web of Science ®Google Scholar
• Report from the Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41, 617–618 (1991).
   PubMed Web of Science ®Google Scholar
• Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 2,750–753 (1978).
   PubMed Web of Science ®Google Scholar
• Witebsky E. Historical roots of present concepts of immunopathology. In: Immnopathology (1st international symposium). Grabar P, Miescher P (Eds). Benno Schwabe, Basel, Switzerland, 1 (1959).
   Google Scholar
• Yuki N, Taki T, Inagaki F et al. A bacterium lipopolysaccharide that elicits Guillain—Barré syndrome has a GM1 ganglioside-like structure. J Exp. Med. 178,1771-1775 (1993).
   Google Scholar
• Yuki N, Yamada M, Koga M et al. Animal model of axonal Guillain—Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49,712-720 (2001).
   Google Scholar
• •Important evidence that immunization with ganglioside can lead to acute motor axonopathy, lending support to the pathogenetic role of antiganglioside antibodies in GBS.
   Google Scholar